Skip to content

PolitiKit

David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

David Goodman

Chief Executive Officer

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
175
Since Nov 2021
205
Active registrations
1

Reported meetings

  • Pharmascience Inc.
    • Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Mike McGuire · Directeur général, Politiques internationales et frontalières, Public Safety Canada (PS)
    • Philippe Roseberry · Directeur, Politiques frontalières, Public Safety Canada (PS)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Jennifer Lutfallah · Vice-présidente de la Direction générale du secteur commercial et des échanges commerciaux, Canada Border Services Agency (CBSA)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Aaron Fowler · SMA associé pour le commerce international et négociateur commercial en chef, Global Affairs Canada (GAC)
    • David Hutchinson · Director General at Global Affairs Canada, Global Affairs Canada (GAC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Celia Lourenco · Sous-ministre adjointe déléguée, Health Canada (HC)
    • Joyce Boye · Directrice générale, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
    • Daniel MacDonald · Director General, Office of Pharmaceutical Management Strategies, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Cloé Tourigny · Parliamentary Intern to Helena Jaczek, House of Commons
    • François Rémillard · Parliamentary Assistant to Jacque Ramsey, House of Commons
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Philip Jennings · Sous-ministre, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Greg Orencsak · Sous-ministre, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Karim Bardeesy · Député
    • Paul Moen · Chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Michael Hahn · Analyste princ. d'investissements, Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

  • Pharmascience Inc.
    • Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Mackenzy Metcalfe · Conseillère en politiques, Finance Canada (FIN)
    • Élyse Moisan · Conseiller politique, Finance Canada (FIN)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Jean-Francois Courtois · Directeur exécutif, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell · Directrice adjointe, Innovation, Science and Economic Development Canada (ISED)
    • Nadeen abd el aal · Analyste princ. de politiques, Innovation, Science and Economic Development Canada (ISED)
    and 1 more
    • Inga Pusca · Gestionnaire princ. d'investissements p. int., Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

  • Pharmascience Inc.
    • Mark Carney · Premier ministre, Prime Minister's Office (PMO)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Mackenzy Metcalfe · Conseillère en politiques, Finance Canada (FIN)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

  • Pharmascience Inc.
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

  • Pharmascience Inc.
    • Sandenga Yeba · Deputy chief of staff and policy director, Health Canada (HC)
    Policies aimed at reinforcing pharmaceutical supply chain.

    Official report

  • Pharmascience Inc.
    • Nadeen Abd El Aal · Analyste princ. de politiques, Innovation, Science and Economic Development Canada (ISED)
    • Inga Pusca · Gestionnaire princ. d'investissements p. int., Innovation, Science and Economic Development Canada (ISED)
    • Jean-Francois Courtois · Directeur exécutif, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
    and 1 more
    • Alison McConnell · Diretrice adjointe, Innovation, Science and Economic Development Canada (ISED)
    Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.